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http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose(s): Trichomoniasis caused by Trichomonas vaginalis is the most common
non-viral sexually transmitted infection. Morphological transformation from the trophozoite
stage to the amoeboid or pseudocyst stage is crucial for T. vaginalis infection and survival.
Protein phosphorylation is a key post-translational modification involved in the regulation of
several biological processes in various prokaryotes and eukaryotes. More than 880 protein
kinases have been identified in the T. vaginalis genome. However, little is known about the
phosphorylation of specific proteins and the distribution of phosphorylated proteins in
different stages of the morphological transformation of T. vaginalis.
Methods: To obtain a more comprehensive understanding of the T. vaginalis phosphopro-
teome, we analyzed phosphorylated proteins in the three morphological stages using titanium
dioxide combined with LC-MS/MS.
Results: A total of 93 phosphopeptides originating from 82 unique proteins were identified.
Among these proteins, 21 were detected in all stages, 29 were identified in two different
stages, and 32 were stage specific.egulation and Bioinformatics Laboratory, Department of Parasitology, College of Medicine, Chung
d, Kweishan, Taoyuan 333, Taiwan.
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Phosphoproteome profiling of Trichomonas vaginalis 367Conclusion: Identification of stage-specific phosphorylated proteins indicates that phosphory-
lation of these proteins may play a key role in the morphological transformation of T. vaginalis.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Trichomonas vaginalis is the causative agent of one of the
most common sexually transmitted diseases, trichomoni-
asis.1 Approximately 5 million cases of trichomonal vaginitis
are reported annually in North America.Worldwide, over 170
million cases of trichomoniasis are reported each year.
Infection is acquired primarily through transmission of
trophozoites by direct sexual contact, although neonatal
infection has also been reported.2 Trichomoniasis is associ-
ated with adverse pregnancy outcomes, enhanced predis-
position to HIV infection and risk of cervical neoplasia.3,4
A unique feature of the T. vaginalis life cycle is the
reversible morphological transformation from the tropho-
zoite stage to the amoeboid or pseudocyst stage. The para-
site multiplies in the vagina or prostate of infected hosts in
the trophozoite form. When it attaches to the surface of
vagina epithelial cells, the trophozoite transforms to an
amoeboid stage and induces acute inflammation of the
vagina, resulting in a yellowish-green foul-smelling discharge
in some females. Transformation to the amoeboid stage is
crucial for establishment and maintenance of T. vaginalis
infection in the vagina. Several proteins that mediate
adherence, such as surface proteins (AP120, AP65, AP51,
AP33, AP23),5,6 cysteine proteinases,7 glyceraldehyde 3-
phosphate dehydrogenase,8 and lipophosphoglycan,9 have
been identified. Increasing evidence demonstrates that T.
vaginalis can survive in the form of a pseudocyst under
unfavorable environmental conditions, such as nutrient
deprivation, the presence of drugs or dramatic changes in
temperature.10 In this form, the parasite becomes non-
motile and the flagellae are internalized, but a true cyst
wall is not formed. Recent studies indicate that the pseu-
docyst stage is reversible and represents a defense mecha-
nism against conditions detrimental to trichomonad
survival.11,12 This pseudocystic stage is probably responsible
for transmission of trichomoniasis via non-sexual contact. At
present, how transformation between the trophozoite,
amoeboid and pseudocyst stages is controlled and regulated
in T. vaginalis remains largely unknown.
The modulation of protein phosphorylation through the
antagonistic effects of protein kinases and protein phospha-
tases is a major regulatory mechanism for most cellular
processes. Protein kinases are one of the major classes of
enzymes involved in signal transduction and signaling
networks. Many growth factors, cytokines and antigens
initiate signaling events through protein phosphorylation,
leading to cellular responses such as gene expression, changes
in cell shape and migration, entry into the cell cycle, and
proliferation. Protein phosphorylation is a major mechanism
by which external stimuli are transformed into intracellular
signals to which cells respond. It has been estimated that
30e50% of intracellular proteins are phosphorylated at some
point in their lifetime.13 The T. vaginalis kinome comprisesmore than 880 eukaryotic protein kinases and 40 atypical
protein kinases, making it one of the largest kinomes identi-
fied to date.14 Large-scale gene expression analysis using
expressed sequence tags showed that 451 kinasegenes (50%of
the kinome) are expressed.At present, it is not known if any of
these kinases participate in the transformation of trophozo-
ites into amoeboids or pseudocysts. An alternative approach
to explore the function of these kinases in the transformation
process is to investigate the phosphoproteome of T. vaginalis
and to use the resulting data set as a basis for deducing the
kinaseesubstrate interaction network. In the present study,
weelucidated theexpressionprofile ofphosphoproteins in the
trophozoite, pseudocyst and amoeboid stages of T. vaginalis
using a reverse-phase LC/MS/MS system.
Methods
Cell culture
T. vaginalis isolate ATCC30236 (JH 31A#4) was maintained in
YISmedium, pH5.8, containing 10% heat-inactivated fetal calf
serum at 37 C.15 The number of viable cells was determined
based on hemocytometer counts using Trypan blue exclusion.
Trophozoites grown to the late logarithmic phase with more
than 90% viable cells were harvested for further study. The
pseudocyst stage was induced by incubating trophozoites in
late logarithmic phase on ice for 4 hours. The amoeboid stage
was induced by growing trophozoites in late logarithmic phase
in fibronectin-coated T-75 flasks for 3 hours at 37 C.
Preparation of cell extracts, digestion of protein
mixtures and enrichment of phosphopeptides
T. vaginalis cells from trophozoites, pseudocysts and amoe-
boids were harvested by centrifugation at 3000 rpm for 15
minutes and were washed there times in normal saline. Cell
pellets were resuspended in lysis buffer (8 M urea, 4% CHAPS)
containing protease inhibitors (Roche Diagnostics, Basel,
Switzerland) atacell densityofapproximately1.2108 cells/
mL. Cells were disrupted by ultrasonication (XL2000, Misonix
Inc., Farmingdale, NY, USA) in an ice bath for eight cycles,
each consisting of 10 seconds of sonication followed by a 10-
second break. After centrifugation at 4 C and 13,000 rpm
for 15 minutes, impurities in the supernatant were removed
using a 2D cleanup kit (GE Healthcare, Taipei, Taiwan). For
tryptic digestion, the protein mixtures were diluted in 50 mM
ammonium bicarbonate (Sigma, St. Louis, MO, USA) and
digested with sequencing-grade trypsin (1:50 w/w; Promega,
Madison, WI, USA) at 56C for 1 hour. The digested lysate was
reduced with 25 mM NH4HCO3 (Sigma) containing 10 mM
dithiothreitol (DTT; Sigma) at 37C for 30 minutes and then
alkylated with 55 mM iodoacetamide (Sigma) at room
temperature for 30 minutes. After further reduction with
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mixtures were digested with sequencing-grade trypsin
(20 mg/mL; Promega) at 37C overnight. The T. vaginalis
phosphopeptides were enriched using a PHOS-TRAP phos-
phopeptide enrichment kit (Perkin Elmer, Waltham, MA, USA)
according to the manufacturer’s protocol.
LC/MS/MS
The enriched phosphopeptides from trophozoites, pseudo-
cysts and amoeboids were separated using a gradient
system on a 10-cm analytical C18 column (inner diameter,
75 mm) with a 15-mm tip (New Objective, Woburn, MA, USA)
as previously described.16 Analytes in the eluent were
detected with an online LTQ-Orbitrap linear ion-trap mass
spectrometer (Thermo Fisher, San Jose, CA, USA).
Sequence database search and data analysis
The resulting MS/MS spectra for the phosphoproteome were
used to search reference amino acid sequencesFigure 1. Flowchart of the experimental work. A summary of
proteins from three different stages of T. vaginalis.downloaded from the TrichDB database (release 1.2;
http://eupathdb.org/eupathdb/) using the X! Tandem
(CYCLONE release)17 and MASCOT search engines (Matrix
Science, London, UK; version 2.2.07). For protein identifi-
cation, mass tolerance of 2 Da was permitted for intact
peptide masses and 1 Da for fragment ions, with allowance
for two missed cleavages in the trypsin digest, oxidized
methionine (þ15.99 Da) and phosphorylation (S, T, Y,
þ79.98 Da) as potential variable modifications and carba-
midomethyl cysteines (C, þ57.05 Da) as fixed modifica-
tions. The experimental data were searched and merged
with different search engine results.
Results
T. vaginalis phosphoproteome
To determine the profile of phosphoproteins expressed in
cells of the three different T. vaginalis stages, total protein
lysates were extracted from trophozoites, pseudocysts and
amoeboids and subjected to in-solution tryptic digestionexperimental procedures for identification of phosphorylated
Table 1 Summary of the T. vaginalis phosphoproteome
Am Z T. vaginalis amoeboid stage; Ps Z T .vaginalis pseudocyst stage; Tr Z T. vaginalis trophozoite stage.
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Figure 3. Percentage of serine, threonine and tyrosine
phosphorylated sites in different stages of T. vaginalis. The
distribution of substrate-specific phosphorylation sites identi-
fied in T. vaginalis is expressed as a percentage of the whole
phosphoproteome.
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The resulting MS and MS/MS spectra were searched against
the TrichDB database (release 1.2) using the MASCOT and X!
Tandem search engines. The experimental design is
summarized as a flowchart in Fig. 1. To increase the accu-
racy of phosphopeptide identification, only phosphopep-
tides that were identified by both search engines were
considered. A total of 93 unique peptides representing 82
proteins were retained for subsequent analysis. A summary
of the phosphopeptides identified is presented in Table 1.
There were 84 peptides with one phosphorylated site, eight
peptides with two phosphorylated sites, and one peptide
with three phosphorylated sites.
Fig. 2 shows the distribution of 82 phosphoproteins
among the different stages of T. vaginalis. A total of 52, 59
and 41 phosphoproteins were expressed in the trophozoite,
pseudocyst and amoeboid stages, respectively. Only 21
common enriched proteins were shared by the three stages;
32 proteins were stage specific, and 29 proteins were
expressed in two different stages. The distribution of the
phosphorylation sites identified is summarized in Fig. 3. The
percentage of phosphorylated serine, threonine and tyro-
sine sites was 71.8%, 21.4% and 6.8%, respectively.
Gene ontology analysis
To obtain an overview of the functional distribution of
phosphoproteins identified in the present study, gene
ontology (GO) annotation terms were used to classify the
phosphorylated proteins into three categories: biological
process, cellular component, or molecular function. The 82
phosphorylated proteins identified were searched against
the NCBI non-redundant (nr) protein database with a cutoff
e-value of 103. The GO annotation of these proteins was
inferred from the results of a sequence homology search
using Blast2GO software.18
A total of 41 of the phosphorylated proteins were
annotated with at least one GO term. Some 28, 34 and 19
proteins were classified into the biological process,
molecular function and cellular component categories,Figure 2. Distribution of enriched phosphorylated proteins
in different stages of T. vaginalis. A total of 93 phosphopep-
tides representing 82 proteins enriched by TiO2 affinity binding
were identified in the trophozoite, pseudocyst and amoeboid
stages of T. vaginalis. The number of enriched proteins in each
stage is indicated. A complete list of the peptides identified is
provided in Table 1.respectively. The distribution of level 2 GO terms in the
three categories is summarized in Fig. 4.Discussion
The 14-3-3 family is a group of highly conserved 30-kDa
proteins expressed in a wide range of organisms and tissues.
This protein family is involved in many biological processes,
including regulation of the cell cycle, cell signaling, intra-
cellular trafficking, transcription and cytoskeletal struc-
ture.19 These regulatory networks are usually involved in
phosphorylation of interacting proteins that show a distinct
preference for a particular 14-3-3 isoform. A number of 14-
3-3 sequences have been isolated from protists and char-
acterized.20 For example, 14-3-3 proteins have been iden-
tified in apicomplexan protozoans such as Plasmodium
falciparum21 and Toxoplasma gondii.22 Expression of 14-3-3
proteins in P. falciparum begins during the ring stage,
increases in young trophozoites, and declines thereafter. In
T. gondii, 14-3-3 protein expression was found in feline
enteroepithelial gametocyte stages, sporozoites, tachy-
zoites and bradyzoites. In addition, screening of cDNA
libraries from Entamoeba histolytica and Trypanosoma
brucei led to the identification of several 14-3-3 protein-
like sequences.22 Although 14-3-3 proteins have been
identified in some parasitic organisms, the biological roles
of these proteins in protists remain unclear and should be
investigated further. Many researchers have speculated
that 14-3-3 proteins play a role in signal transduction
related to cellular processes such as proliferation, migra-
tion and morphological changes during the parasite life
cycle. In the present study, we demonstrated that a 14-3-3
protein (TVAG_256840) can be phosphorylated in different
stages of T. vaginalis, a result that has not been reported
previously. These results suggest that 14-3-3 phosphoryla-
tion may be a crucial post-translational modification that
allows T. vaginalis to adapt to diverse environments.
We previously established a proteome reference map for
T. vaginalis by 2D electrophoresis combined with MALDI-
Figure 4. Gene ontology of putative phosphorylated proteins in T. vaginalis. Functional classifications of enriched T. vaginalis
phosphoproteins based on biological process, cellular component and molecular function. The number of phosphoproteins iden-
tified in each gene ontology category is indicated on the right of the histogram.
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to carbohydrate metabolism represented the most abun-
dant category, accounting for 24.7% of all proteins. This
result implies that carbohydrate metabolism may be one of
the most important physiological processes in T. vaginalis.
Several glycolytic enzymes have been described in previous
studies24; however, regulation of carbohydrate metabolism
has not been elucidated in T. vaginalis or in other protists.
In this study, we demonstrated that glucokinase
(TVAG_260790) and glycogen phosphorylase (TVAG_348330)
are phosphorylated in different stages of T. vaginalis,
suggesting that regulation of glucose homeostasis is
a crucial physiological process for T. vaginalis under
different conditions. A previous study showed that gluco-
kinase (GK) purified from rat liver can be phosphorylated on
a serine residue by protein kinase A (PKA).25 A later study
confirmed that GK phosphorylation by PKA led to
a concomitant decrease in GK activity.26 Conversely, GK
activation results in an increase in glucose 6-P concentra-
tion, which has a synergistic effect with glucose in
promoting dephosphorylation and thus inactivation of
glycogen phosphorylase (GP).27 Moreover, defects in both
GK activation and GP dephosphorylation may contribute to
dysregulation of glucose concentrations, resulting in type 2
diabetes in humans. On the basis of previous observations,
we postulate that T. vaginalis may have a similar regulatory
system to modulate glucose concentrations. Phosphopro-
teins identified in all three stages of T. vaginalis, such as
14-3-3 protein and several glycolytic enzymes, have also
been identified in other higher organisms, suggesting that
these proteins are highly conserved and their phosphory-
lation signals are essential in different stages.
We identified several peptides that are phosphorylated
only in the trophozoite stage (Table 1). Eukaryotic peptidechain release factors (eRF) (TVAG_003250) composed of
eRF1 and eRF3 are associated with translation termination
in eukaryotes.28 eRF1 recognizes all three stop codons and
induces hydrolysis of the peptidyletRNA bond. eRF3 carries
four GTP-binding motifs associated with eRF1 to form
a complex and stimulates eRF1 release activity in a GTP-
dependent manner.29 However, eRF3 may have non-
translational functions, such as cell cycle regulation and
cytoskeleton organization. Further functional character-
ization demonstrated that eRF3 depletion decreases the
global translation rate and reduces TOR activity.30
It is currently thought that the pseudocyst stage is
irreversible and represents a defense form. Hence, a better
understanding of the regulation of pseudocyst formation
may provide additional information for the development of
new therapeutics against trichomoniasis.
The serine/threonine protein phosphatase 2A (PP2A)
(TVAG_008140) family is a large family of heterotrimeric
enzymes that are highly conserved in all eukaryotes.
Studies have demonstrated that PP2A activity is crucial for
cell cycle regulation, cell survival, embryonic development
and stress responses.31,32 More recently, attention has
focused on the involvement of PP2A in tumorigenesis
through regulation of cell transformation, which requires
remarkable changes in cytoskeleton remodeling. Several
cell types, such as neutrophils, hepatocytes, endothelial
and epithelial cells, treated with PP2A inhibitors exhibit F-
actin disorganization, cell rounding and loss of cell polarity,
suggesting that PP2A has a role in cytoskeleton organiza-
tion.33 In addition, other findings in plants indicate that
okadaic acid, a PP2A inhibitor, enhances the cold response
in wheat, tomato and Brassica napus leaves, suggesting
that PP2As act as native regulators of low-temperature
responses.34 Given the importance of PP2A in regulation
372 Y.-M. Yeh et al.of the cytoskeleton and cold stress responses in other
organisms, it would be worth studying the role of PP2A in
the response to low temperature and in pseudocyst
formation by T. vaginalis.
There have been many attempts to elucidate the roles of
adhesion-related proteins in the pathogenesis of T. vagi-
nalis; however, how the regulation of these proteins is not
well understood. Calreticulin (CRT; TVAG_120870) is the
only amoeboid-specific phosphorylated protein identified.
It is a calcium (Ca2þ)-binding protein with multiple func-
tions and is predominantly located in the endoplasmic
reticulum (ER). CRT is highly conserved in a diverse range of
species.35 In protists, the physiological and pathological
significance of CRT remains to be defined. Entamoeba his-
tolytica CRT (EhCRT) is remarkably immunogenic in
patients with invasive amoebiasis.36 In addition, EhCRT may
play an important role in adapting to a new environment
during the early stages of infection. In Trypanosoma cruzi,
CRT translocates from the ER to the area of flagellum
emergence and allows the parasite to recruit the comple-
ment component C1, which inhibits the classical pathway of
human complement activation.37 It has been proved that T.
cruzi CRT is a novel virulence factor that promotes infec-
tivity.38 It has also been shown that CRT may regulate
cellular adhesion and the expression of several adhesion-
related proteins, such as vinculin and N-cadherin.39
Another study revealed that CRT is regulated by protein
kinase C (PKC).40 One of the post-translational modifica-
tions induced by PKC activation is tyrosine phosphorylation
in CRT. Since CRT is involved in cellular adhesion and even
in virulence of some protists, characterization of CRT in T.
vaginalis may shed light on the regulation of adherence and
further our understanding of the pathogenesis of T. vagi-
nalis. The stage-specific phosphoproteins unique to T.
vaginalis may play a role in the signaling involved in
morphological transformation of the parasite.
The distribution of phosphoproteins identified in the
three stages implies that different signal transduction
cascades are activated. GO analysis of 41 annotatable
proteins revealed that most proteins are located in the cell
and have a binding function. The phosphopeptides detec-
ted in different stages revealed possible roles in the regu-
lation of phosphorylation-based signaling pathways. The
phosphoproteomics data sets generated in the present
study will serve as a foundation for further characterization
of the functions of these phosphoproteins. This could ulti-
mately help in the identification of potential drug targets
for the treatment of T. vaginalis infection.
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